MannKind
Présence
MannKind fait partie des...
MannKind est une société cotée sous le symbole boursier MNKD (US).
Dirigeants
Voir l'organigramme avec ses 22 principaux dirigeants
Biographies les plus recherchées chez MannKind
- Michael Castagna, Chief Executive Officer and Director
- Michael Friedman, Director
- Kent Kresa, Director
Changements de dirigeants chez MannKind
- Christopher Prentiss rejoindra l'entreprise comme Chief Financial Officer le 22 avr. 2024 (publié le 27 mars 2024).
Créer une alerte
pour suivre les mouvements de dirigeants chez MannKind.
Pharmacie
MannKind a 1 860 concurrents dont Pfizer (Etats—Unis), Sanofi (France) et Johnson & Johnson (Etats—Unis).
Actualités en fusion/acquisition en Pharmacie.
- MedMen has filed for bankruptcy protection (publié le 28 avril 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publié le 23 mars 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publié le 19 mars 2024).
Contacts en Pharmacie
Actualités
Derniers communiqués de presse par MannKind
- MannKind Repays Certain Debt Obligations | MannKind Corporation
- MannKind Announces CFO Transition | MannKind Corporation
- MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8 | MannKind Corporation
- MannKind Corporation Announces Participation at Upcoming Conferences | MannKind Corporation
- INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps | MannKind Corporation
- MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024 | MannKind Corporation
- MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update | MannKind Corporation
- MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza® | MannKind Corporation
- MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million | MannKind Corporation
- MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference | MannKind Corporation
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de MannKind
- MannKind sur Wikipédia, Google News & Yahoo Finance en 1-click
- MannKind sur LinkedIn, Twitter & YouTube en 1-click
Entrer en contact
Contacter par email ses dirigeants dont Michael Castagna 
